Crossmark

Improving diabetic patients’ adherence to treatment and prevention of cardiovascular disease (Office Guidelines Applied to Practice—IMPACT Study)—a cluster randomized controlled effectiveness trial

Crossref DOI link: https://doi.org/10.1186/s13063-022-06581-6

Published Online: 2022-08-15

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Olomu, Adesuwa

Kelly-Blake, Karen

Hart-Davidson, William

Gardiner, Joseph

Luo, Zhehui

Heisler, Michele

Holmes-Rovner, Margaret
Funding

Funding for this research was provided by:

National Institutes of Health (5R01HL149777-03)
License Information

Text and Data Mining valid from 2022-08-15

Version of Record valid from 2022-08-15
More Information

Article History

Received: 20 May 2022

Accepted: 20 July 2022

First Online: 15 August 2022

Declarations

:

: This study has been approved by Michigan State University IRB, Biomedical and Health Institutional Review Board, MSU Study ID: STUDY00004464. All participating patients will provide written informed consent.

: This manuscript does not contain individual personal data from patients. Informed consent materials are attached as InternalRef removed.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below